AGM Report

GlaxoSmithKline (GSK) AGM 2016

AGM Date: May 5, 2016

Report Author: Stan Grierson

As usual it was an afternoon meeting at 2:30 pm in the Queen Elizabeth II Conference Centre, with one of the biggest audiences I have ever seen there. All the overflow areas were also full. This is one of our biggest companies, with a turnover this year of £23.9bn (£223.0bn) and a total profit declared at £10.3bn (£3.6bn). Sir Phillip Hampton, the new Chairman, appointed 1st January this year, opened the meeting on time. He started positively, emphasising the tremendous reorganisation which has and is taking place at present. He and the CEO Sir Andrew Witty then explained the organisation and the progress in product releases, and where the company is going. It was a good story. We note that the CEO’s remuneration is £6.7m (£3.9m), up from last year

...

Not a member? Join today

Joining ShareSoc helps to empower our collective voice in representing investors, but we also offer exclusive benefits:

Member events & Masterclasses
Regular newsletter
Member only on-line Forums / Q&As
Company data and Voting Guidance
Educational resources
Get involved in our activities

Join now